GEMPHIRE THERAPEUTICS INC - COM (GEMP)

CUSIP: 36870A108

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
3,305,410
Share change
-108,358
Total reported value
$26,413,000
Price per share
$7.95
Number of holders
28
Value change
-$879,756
Number of buys
11
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 36870A108?
CUSIP 36870A108 identifies GEMP - GEMPHIRE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GEMPHIRE THERAPEUTICS INC - COM (GEMP) as of Q4 2017

As of 31 Dec 2017, GEMPHIRE THERAPEUTICS INC - COM (GEMP) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,305,410 shares. The largest 10 holders included Cormorant Asset Management, LLC, Exchange Capital Management, Inc., NORTHPOINTE CAPITAL LLC, BAMCO INC /NY/, ADAGE CAPITAL PARTNERS GP, L.L.C., Vanguard Group Inc, Cambridge Investment Research Advisors, Inc., COMERICA BANK, BRIDGEWAY CAPITAL MANAGEMENT INC, and RAYMOND JAMES & ASSOCIATES. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.